جلابتيفيا 100 مجم 14 قرص

ما هو دواء جلابتيفيا 100 مجم 14 قرص

جرعة دواءجلابتيفيا 100 مجم 14 قرص

يستعمل دواء جلابتيفيا 100 مجم 14 قرصglaptivia 100 mg 14 f.c.tab. anti-diabetic.secretagogues.dpp-4 inhibitors anti-diabetic.secretagogues.dpp-4 inhibitors

about sitagliptin -antidiabetic agent oral hypoglycaemic -mechanism of action of sitagliptin -vildagliptin is a dipeptidylpeptidase-4 (dpp-4) inhibitor that improves glycaemic control by preventing dpp-4 from inactivating the incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide thus prolonging incretin activity in response to ingestion of nutrients. this increases insulin sensitivity decreases glucagon secretion and improves -cell function. -indications for sitagliptin -type 2 diabetes mellitus -interactions for sitagliptin -digoxin: increase concentration of digoxin -increased risk of hypoglycaemia when used with other anti-diabetic agents

تركيبة دواءجلابتيفيا 100 مجم 14 قرصglaptivia 100 mg 14 f.c.tab.

يتركب هذا الدواء من :sitagliptin